Saruwatari J, Matsunaga M, Ikeda K, Nakao M, Oniki K, Seo T, Mihara S,
Marubayashi T, Kamataki T, Nakagawa K.
Impact of CYP2D6*10 on the H1-antihistamine induced hypersomnia.
Eur. J. Clinical. Pharmacol. 62, 995-1001, 2006.

Dosman JA, Fukushima Y, Senthilselvan A, Kirychuk SP, Lawson JA, Pahwa P, Cormier Y, Hurst T, Barber EM, Rhodes CS.
Respiratory response to endotoxin and dust predicts evidence of inflammatory response in volunteers in a swine barn.
Am. J. Ind. Med. 49, 761-766, 2006.

Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K.
ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Pharmacogenomics 7, 551-561, 2006.

Seo T, Nakada N, Ishitsu T, Ueda N, Hagiwara T, Hashimoto N, Nakagawa K.
Effect of CYP3A5*3 on the carbamazepine pharmacokinetics in Japanese patients with epilepsy.
Clin. Pharmacol. Ther. 79, 509-510, 2006.

Takata K, Saruwatari J, Nakada N, Nakagawa M, Fukuda K, Tanaka F,
Takenaka S, Mihara S, Marubayashi T, Nakagawa K.
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
Eur. J. Clin. Pharmacol. 62, 23-28, 2006.

McDuffie HH, Nakagawa K, Pahwa P, Shindo J, Hashimoto M, Nakada N,
Gosh S, Kirychuk SP, Hucl P.
Tumour necrosis factor alpha and pulmonary Function in Saskatchewan grain handlers.
J. Occup. Environ. 48, 505-511, 2006.

村田 司, 瀬尾享志, 櫻井眞治, 橋本奈味, 中川和子, 石津棟暎.
重症心身障害児（者）における低ナトリウム血症の検討.
日本重症心身障害学会誌, 31, 263-268, 2006.